These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37742362)

  • 101. Design, optimization and pharmacokinetic evaluation of PLGA phosphatidylcholine hybrid nanoparticles of triamcinolone acetonide loaded in situ gel for topical ocular delivery.
    Shareef Khan M; Rao Ravi P; Shrikant Dhavan D
    Int J Pharm; 2023 Nov; 647():123530. PubMed ID: 37858638
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Dose identification of triamcinolone acetonide for noninvasive pre-corneal administration in the treatment of posterior uveitis using a rapid, sensitive HPLC method with photodiode-array detector.
    Khan MS; Ravi PR; Mullapudi TVR
    Biomed Chromatogr; 2022 Feb; 36(2):e5264. PubMed ID: 34653273
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Optimization and in vivo evaluation of triamcinolone acetonide loaded in situ gel prepared using reacted tamarind seed xyloglucan and kappa-carrageenan for ocular delivery.
    Khan MS; Ravi PR; Mir SI; Rawat PS
    Int J Biol Macromol; 2023 Apr; 233():123533. PubMed ID: 36740111
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Polymer Nanoparticles with 2-HP-β-Cyclodextrin for Enhanced Retention of Uptake into HCE-T Cells.
    Qin Z; Li B; Deng Q; Wen Y; Feng S; Duan C; Zhao B; Li H; Gao Y; Ban J
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338402
    [TBL] [Abstract][Full Text] [Related]  

  • 105. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
    Jonas JB; Kreissig I; Kamppeter B; Degenring RF
    Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
    [TBL] [Abstract][Full Text] [Related]  

  • 106. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
    Jonas JB; Kreissig I; Degenring RF
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Triamcinolone acetonide. A review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis.
    Jeal W; Faulds D
    Drugs; 1997 Feb; 53(2):257-80. PubMed ID: 9028745
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Efficacy and safety of intravitreal and periocular injection of corticosteroids in noninfectious uveitis: a systematic review.
    José-Vieira R; Ferreira A; Menéres P; Sousa-Pinto B; Figueira L
    Surv Ophthalmol; 2022; 67(4):991-1013. PubMed ID: 34896190
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Intravitreal triamcinolone acetonide: a change in a paradigm.
    Jonas JB
    Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Design, optimization, in vitro and in vivo evaluation of triamcinolone acetonide nanocrystals loaded in situ gel for topical ocular delivery.
    Khan MS; Ravi PR; Dhavan DS
    Colloids Surf B Biointerfaces; 2023 Nov; 231():113539. PubMed ID: 37742362
    [TBL] [Abstract][Full Text] [Related]  

  • 111.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 112.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 113.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 114.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 6.